NEI SBIR Phase I — Feasibility
Supports United States. small businesses testing vision concepts through feasibility-focused grants.
The NEI SBIR Phase I program provides proof-of-concept funding to US small businesses developing innovative vision-related technologies with commercial potential. The National Eye Institute funds research across ten extramural program areas: retina (including age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa), cornea, lens and cataract, glaucoma and optic neuropathie…
Vision-related R&D: retina, glaucoma, cornea, lens, low vision, amblyopia/strabismus, and related ocular/visual technologies with commercial potential.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline